Advertisement

Topics

deCODE genetics Company Profile

01:37 EDT 20th September 2017 | BioPortfolio

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease.The company currently has eight lead programs in drug discovery and development, including compounds in clinical trials for heart attack, peripheral artery disease and asthma.

Location

584 Broadway, Suite 608
New york
New York
10012
United States of America

Contact

Phone: (212) 343 2819
Email: info@decode.is


News Articles [711 Associated News Articles listed on BioPortfolio]

ASHG honors Kári Stefánsson with William Allan Award

(American Society of Human Genetics) The American Society of Human Genetics (ASHG) has named Kári Stefánsson, M.D., founder of deCODE Genetics, the 2017 recipient of the annual William Allan Award. ...

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 02052017] Prices from USD $350

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments re...

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments re...

H. Lundbeck A/S: Lundbeck collaborates on large first-of-its kind study of links between genetics and psychiatric disorders

25,000 patients will be enrolled in the first study ever to combine data from genetics, cognitive tests and online surveys to explore how genetics is related to Major Depressive Disorder, Bipolar D...

Cancer Genetics acquires vivoPharm

Cancer Genetics and vivoPharm have entered into a definitive agreement for Cancer Genetics to acquire vivoPharm for approximately $12 million. This transaction will significantly strengthen CGI’s ...

$0.21 Earnings Per Share Expected for Myriad Genetics, Inc. (MYGN) This Quarter

Wall Street brokerages forecast that Myriad Genetics, Inc. will post earnings of $0.21 per share for the current quarter, Zacks reports. Five analysts have made estimates for Myriad Genetics' earn...

ASHG honors Daniel MacArthur with inaugural Early-Career Award

(American Society of Human Genetics) ASHG has named Daniel MacArthur, Ph.D., Assistant Professor in the Analytic and Translational Genetics Unit at Massachusetts General Hospital and Harvard Medical S...

Interleukin Genetics slashes workforce, explores options

The genetics testing company is evaluating strategic alternatives, and plans to shutter one of its lead programs and dismiss more than half its staff.

Drugs and Medications [0 Results]

None

PubMed Articles [706 Associated PubMed Articles listed on BioPortfolio]

The Clinic Is My Laboratory: Life as a Clinical Geneticist.

Clinical genetics is the application of advances in genetics and medicine to real human families. It involves diagnosis, care, and counseling concerning options available to affected individuals and t...

Introduction to behavioral phenotypes in medical genetics.

25 more years.

This month, to celebrate a quarter century of excellence in genetics, we are highlighting selections from the past work we have published. We will then publish a number of forward-looking Perspectives...

Ocular genetics in Taiwan.

Ocular genetics is an emerging specialty which has accompanied the advancement of modern genetic technology. This review is to understand the current status of practice in ocular genetics in Taiwan.

In This Issue.

Clinical Trials [283 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

The results from the DECODE Study have shown that postprandial (1 - 2 hours after a meal) hyperglycemia (elevated blood sugar) is more common in elderly people with diabetes than younger p...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [42 Associated Companies listed on BioPortfolio]

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE...

deCode

Based in Reykjavik, Iceland, deCODE genetics is a population-based genomics company conducting research into the inherited causes of common diseases. The company operates one of the most technological...

deCODE genetics

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach ...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

deCODE chemistry

deCODE chemistry offers chemistry-based drug discovery and development services including early-stage lead discovery and optimization, process chemistry research for development of optimal synthetic r...

More Information about "deCODE genetics" on BioPortfolio

We have published hundreds of deCODE genetics news stories on BioPortfolio along with dozens of deCODE genetics Clinical Trials and PubMed Articles about deCODE genetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of deCODE genetics Companies in our database. You can also find out about relevant deCODE genetics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record